The truest testaments to Siteman Cancer Center’s expertise are the prestigious organizations that have welcomed us into their venerable ranks since our founding in 1999. Membership in such organizations has helped us gather the funding and resources necessary to become leaders in cancer research and treatment from diagnosis through survivorship, and beyond.

NCI Designation

Siteman Cancer Center received the esteemed Comprehensive Cancer Center designation from the National Cancer Institute (NCI), the United States government’s principal agency for cancer research and training, in 2005.

The comprehensive designation was awarded through the NCI’s cancer centers program and is its highest level of distinction, which can only be awarded after a center has undergone a rigorous review by experts in the cancer field.

Siteman was awarded comprehensive status because of its expertise in every phase of the cancer journey, including its basic and clinical research programs; programs in cancer prevention, control and population-based research; outreach and education efforts for residents and health-care professionals in the St. Louis region and interactive research that bridges these disciplines.

As part of this comprehensive designation, Siteman Cancer Center received a support grant from the NCI that provides funding for programs and specialized services in multidisciplinary research, shared scientific resources and seed awards that enable our scientists to develop and pursue new research opportunities.

In 2015, the NCI awarded Siteman Cancer center an “exceptional” rating, based on a rigorous review of Siteman’s research programs.

NCCN Membership

In 2006 Siteman Cancer Center became one of the 25 institutions that make up the National Comprehensive Cancer Network (NCCN), a nonprofit alliance of the world’s leading cancer centers dedicated to improving the quality, efficiency and effectiveness of cancer care.

As an NCCN member, Siteman plays an integral role in developing resources that present valuable information to cancer patients, healthcare providers and other groups by creating guidelines for treatment and clinical practice, distributing clinical trial information and planning educational conferences and literature.